Comparison between Falcon Technoprojects IPO and Medicamen Organics IPO.
Falcon Technoprojects IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Medicamen Organics IPO is a SME Bookbuilding proposed to list at NSE SME.
| Falcon Technoprojects IPO | Medicamen Organics IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Kunvarji Finstock Pvt.Ltd. | GYR Capital Advisors Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | Kfin Technologies Ltd. |
| Market Maker | Nikunj Stock Brokers Ltd. | Giriraj Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Falcon Technoprojects IPO is up to ₹13.01 Cr whereas the issue size of the Medicamen Organics IPO is up to ₹9.96 Cr. The final issue price of Falcon Technoprojects IPO is ₹92.00 per share and of Medicamen Organics IPO is ₹34.00 per share.
| Falcon Technoprojects IPO | Medicamen Organics IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹32.00 per share | |
| Issue Price (Upper) | ₹34.00 per share | |
| Issue Price (Final) | ₹92.00 per share | ₹34.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 4000 shares |
| Fresh Issue Size | 14,13,600 shares | 29,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹13.01 Cr | up to ₹9.96 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 14,13,600 shares | 29,28,000 shares |
| Issue Size Total (Amount) | up to ₹13.01 Cr | up to ₹9.96 Cr |
Falcon Technoprojects IPO opens on Jun 19, 2024, while Medicamen Organics IPO opens on Jun 21, 2024. The closing date of Falcon Technoprojects IPO and Medicamen Organics IPO is Jun 21, 2024, and Jun 25, 2024, respectively.
| Falcon Technoprojects IPO | Medicamen Organics IPO | |
|---|---|---|
| Anchor Bid Date | Jun 20, 2024 | |
| Issue Open | Jun 19, 2024 | Jun 21, 2024 |
| Issue Close | Jun 21, 2024 | Jun 25, 2024 |
| Basis Of Allotment (Tentative) | Jun 24, 2024 | Jun 26, 2024 |
| Initiation of Refunds (Tentative) | Jun 25, 2024 | Jun 27, 2024 |
| Credit of Share (Tentative) | Jun 25, 2024 | Jun 27, 2024 |
| Listing date (Tentative) | Jun 26, 2024 | Jun 28, 2024 |
| Anchor Lockin End date 1 | Jul 26, 2024 | |
| Anchor Lockin End date 2 | Sep 24, 2024 |
Falcon Technoprojects IPO P/E ratio is 34.25, as compared to Medicamen Organics IPO P/E ratio of 30.53.
| Falcon Technoprojects IPO | Medicamen Organics IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 84.20 | 81.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 34.25 | 30.53 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹49.28 Cr. | ₹39.78 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 9.68% | 19.90% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 11.54% | 14.50% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.83 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.69 | ₹1.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 9.68% | 15.83 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Falcon Technoprojects IPO Retail Individual Investors (RII) are offered 7,06,800 shares while in Medicamen Organics IPO retail investors are offered 7,06,800 shares. Qualified Institutional Buyers (QIB) are offered in Falcon Technoprojects IPO and 5,84,000 shares in Medicamen Organics IPO.
| Falcon Technoprojects IPO | Medicamen Organics IPO | |
|---|---|---|
| Anchor Investor Reservation | 8,76,000 shares | |
| Market Maker Reservation | 74,400 shares | 1,72,000 shares |
| QIB | 5,84,000 shares | |
| NII | 7,06,800 shares | 4,40,000 shares |
| RII | 7,06,800 shares | 10,28,000 shares |
| Employee | ||
| Others | ||
| Total | 14,13,600 shares | 29,28,000 shares |
Falcon Technoprojects IPO subscribed 65.32x in total, whereas Medicamen Organics IPO subscribed 993.56x.
| Falcon Technoprojects IPO | Medicamen Organics IPO | |
|---|---|---|
| QIB (times) | 173.03x | |
| NII (times) | 45.02x | 1,343.83x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 82.72x | 1,309.77x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 65.32x | 993.56x |
